Skip to main content
. 2022 May 18;9(7):1011–1026. doi: 10.1002/acn3.51579

Figure 2.

Figure 2

Linear regression relationship between the relative expression of the analysed microRNAs at baseline and the response to nusinersen treatment assessed using the difference between the CHOP‐INTEND (A) and HINE (B) scores at 2 months to the baseline score. Presented are the regression line with 95% confidence intervals of the best fit line and the regression equation. CHOP‐INTEND, Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders; HINE, Hammersmith Infant Neurological Examination Section 2.